[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 6, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.5, "open": 6.5, "dayLow": 6.315, "dayHigh": 6.575, "regularMarketPreviousClose": 6.5, "regularMarketOpen": 6.5, "regularMarketDayLow": 6.315, "regularMarketDayHigh": 6.575, "payoutRatio": 0.0, "beta": 2.771, "trailingPE": 2.3163636, "forwardPE": -39.8125, "volume": 3786451, "regularMarketVolume": 3786451, "averageVolume": 9018787, "averageVolume10days": 5330310, "averageDailyVolume10Day": 5330310, "bid": 6.24, "ask": 6.5, "bidSize": 1, "askSize": 50, "marketCap": 1031748864, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 17.81, "priceToSalesTrailing12Months": 0.8221355, "fiftyDayAverage": 6.7344, "twoHundredDayAverage": 8.54015, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 528931040, "profitMargins": 0.38144, "floatShares": 136652754, "sharesOutstanding": 161970000, "sharesShort": 44482397, "sharesShortPriorMonth": 46467707, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.2746, "heldPercentInsiders": 0.087799996, "heldPercentInstitutions": 0.5729, "shortRatio": 4.04, "shortPercentOfFloat": 0.2756, "impliedSharesOutstanding": 161970000, "bookValue": -0.467, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 478696992, "trailingEps": 2.75, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.421, "enterpriseToEbitda": 1.131, "52WeekChange": -0.4996072, "SandP52WeekChange": 0.12748289, "quoteType": "EQUITY", "currentPrice": 6.37, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 13.42857, "targetMedianPrice": 10.0, "recommendationMean": 2.57143, "recommendationKey": "hold", "numberOfAnalystOpinions": 7, "totalCash": 731478976, "totalCashPerShare": 4.516, "ebitda": 467502016, "totalDebt": 228659008, "quickRatio": 1.783, "currentRatio": 2.056, "totalRevenue": 1254962048, "revenuePerShare": 7.969, "returnOnAssets": 0.1997, "grossProfits": 732558016, "freeCashflow": 61875752, "operatingCashflow": -189210000, "revenueGrowth": 6.103, "grossMargins": 0.58373, "ebitdaMargins": 0.37252, "operatingMargins": 0.77402997, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -2.0, "regularMarketPrice": 6.37, "marketState": "CLOSED", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "fiftyTwoWeekLowChange": 1.3599997, "fiftyTwoWeekLowChangePercent": 0.27145702, "fiftyTwoWeekRange": "5.01 - 17.81", "fiftyTwoWeekHighChange": -11.44, "fiftyTwoWeekHighChangePercent": -0.6423358, "fiftyTwoWeekChangePercent": -49.96072, "dividendDate": 1557446400, "earningsTimestamp": 1746705608, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1746707400, "earningsCallTimestampEnd": 1746707400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 2.75, "epsForward": -0.16, "epsCurrentYear": 2.10251, "priceEpsCurrentYear": 3.0297122, "fiftyDayAverageChange": -0.3643999, "fiftyDayAverageChangePercent": -0.05411023, "twoHundredDayAverageChange": -2.1701498, "twoHundredDayAverageChangePercent": -0.25411144, "priceToBook": -13.640257, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": 0.15698947, "postMarketPrice": 6.38, "postMarketChange": 0.010000229, "regularMarketChange": -0.13, "regularMarketDayRange": "6.315 - 6.575", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 9018787, "corporateActions": [], "postMarketTime": 1751068528, "regularMarketTime": 1751054401, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]